Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
“Lenalidomide (Revlimid) induced a 72% reduction in the risk of progression to symptomatic disease in patients with smoldering multiple myeloma at 3 years” The challenge with pre-myeloma, MonoclonalContinue reading
Pre-MM diagnosis (MGUS, SMM)? Don’t watch and wait. Undergo evidence-based, non-toxic therapies shown to kill MM- Pre-Myeloma is comprised of 3 diagnoses- SBP, MGUS and SMM. MGUS and SMM are consideredContinue reading
Diagnostic Testing For Cancer Is Tricky-Particularly early stage Breast or Prostate cancer- Written by a credible source, Gilbert Welch is a medical doctor and a professor at the Dartmouth Institute forContinue reading
“…there exists no evidence to suggest that early intervention in Soldering Multiple Myeloma, even when limited to patients at highest risk of progression to active MM, leads to improved overallContinue reading
Now we have to wonder how long the lesion (pre-myeloma) will sit there. We can’t pretend they’re not there, but we don’t know what they mean. A single plasmacytoma (SBP), monoclonal gammopathy ofContinue reading
Based on the current evidence, early treatment didn’t significantly affect mortality and response rate… The diagnosis of an incurable cancer like multiple myeloma is awful. Patients feel as ifContinue reading
A recent update confirmed an overall survival advantage after a median follow-up of more than six years,”How can overall survival be measured in pre-Multiple Myeloma (MGUS, SMM)? The oncologist inContinue reading